Genetic Engineering and Biotechnology
이 집합의 용어 (19)
Genetic engineering is the alteration of an organism’s genome, typically using recombinant DNA technologies to add or remove genes, producing genetically modified organisms (GMOs).
Biotechnology utilizes living organisms to create products or processes that improve life for humans or other organisms.
Biopharming is the production of pharmaceutically important proteins in genetically modified plants and animals, enabled by recombinant DNA technology.
Examples include insulin, erythropoietin (anemia), human growth hormone (dwarfism), clotting factors, interferons (multiple sclerosis, cancer), and antibodies.
The human insulin gene was cloned into a plasmid, introduced into E. coli, producing fusion proteins that were purified and cleaved to release active insulin subunits.
A fusion protein is a hybrid protein where two polypeptides are linked without stop or start codons between them, used to express short peptides in E. coli.
Bacteria cannot perform post-translational modifications like glycosylation or phosphorylation, so eukaryotic hosts like yeast, insect, or mammalian cells are used for proper protein folding and activity.
Inactivated vaccines use killed pathogens; attenuated vaccines use live but weakened pathogens that cause mild disease.
A subunit vaccine contains only specific surface proteins from a pathogen, produced via recombinant DNA technology, and cannot cause infection.
DNA vaccines deliver DNA encoding pathogen proteins into cells, which then produce antigens to stimulate immunity; they are safer and easier to manufacture than traditional vaccines.
mRNA vaccines do not integrate into the human genome, making them safer, but require low-temperature storage.
Benefits include improved growth, increased yield, enhanced nutrition, and resistance to herbicides, insects, viruses, and drought.
They are used for fundamental gene studies, disease models, producing pharmaceuticals in milk, and improving livestock disease resistance.
A knockout organism has a specific gene disrupted by homologous recombination with a mutated copy, producing a nonfunctional protein to study gene function.
A knock-in animal has a gene inserted at a specific site, such as producing human antithrombin in goat milk for therapeutic use.
By inserting the lysostaphin gene from Staphylococcus simulans, which produces a protein that destroys S. aureus, the cause of mastitis.
Gene testing detects DNA mutations linked to single-gene diseases, used for prenatal diagnosis, carrier identification, disease prediction, and embryo screening.
ASOs are short DNA probes that detect specific alleles differing by single nucleotide polymorphisms (SNPs), used in PCR-based genetic tests.
Membranes hybridized with ASOs complementary to normal or mutant sequences show binding only to matching alleles, identifying genotype.